EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study.

Quantitative EEG (QEEG) has demonstrated good discriminative capacity for dementia with Lewy bodies (DLB) diagnosis as compared to Alzheimer's disease (AD) with a predictive value of 100% in a single cohort study. EEG in DLB was characterized by a dominant frequency (DF) in pre-alpha (5.5-7.5 Hz), theta, or delta bands and DF variability (DFV) >1.2 Hz, frequency prevalence (FP) pre-alpha in >40% and FP alpha in <32% of the epochs. To validate the aforementioned QEEG findings in independent cohorts of clinically diagnosed DLB versus AD patients, we analyzed EEG traces of 79 DLB and 133 AD patients (MMSE >20) collected from four European Centers. EEG traces from 19 scalp derivations were acquired as at least 10 min continuous signals and epoched in off-setting as series of 2-second-long epochs, subsequently processed by Fast Fourier Transform (frequency resolution 0.5 Hz). DLB patients showed EEG specific abnormalities in posterior derivations characterized by DF <8 Hz FP pre-alpha >50%, FP alpha <25%. DFV was >0.5 Hz. AD patients displayed stable alpha DF, DFV <0.5 Hz, FP pre-alpha <30%, and FP alpha >55%. DLB and AD differed for DF (p < 10-6), DFV (p < 0.05), FP pre-alpha (p < 10-12) and FP alpha (p < 10-12). Discriminant analysis detected specific cut-offs for every EEG mathematical descriptor; DF = 8, DFV = 2.2 Hz, FP pre-alpha=33%, FP alpha = 41% for posterior derivations. If at least one of the cut-off values was met, the percentage of DLB and AD patients correctly classified was 90% and 64%, respectively. The findings in this multicenter study support the validity of QEEG analysis as a tool for diagnosis in DLB patients.

[1]  Dag Aarsland,et al.  Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. , 2004, Archives of neurology.

[2]  G. Halliday,et al.  The progression of pathology in Parkinson's disease , 2010, Annals of the New York Academy of Sciences.

[3]  L. Wilkins.  The reproductive effects of beta interferon therapy in pregnancy: A longitudinal cohort , 2005 .

[4]  John-Paul Taylor,et al.  Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences , 2014, Cerebral cortex.

[5]  L. Thal,et al.  Cognitive decline is faster in Lewy body variant than in Alzheimer's disease , 1998, Neurology.

[6]  M. Onofrj,et al.  EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up. , 2008, Brain : a journal of neurology.

[7]  D. Aarsland,et al.  Time until nursing home admission in people with mild dementia: comparison of dementia with Lewy bodies and Alzheimer's dementia , 2014, International journal of geriatric psychiatry.

[8]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[9]  L. Thal,et al.  Diagnostic accuracy of dementia with Lewy bodies. , 2000, Archives of neurology.

[10]  Z Walker,et al.  Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand , 2002, Journal of neurology, neurosurgery, and psychiatry.

[11]  Christos Davatzikos,et al.  Clinical and multimodal biomarker correlates of ADNI neuropathological findings , 2013, Acta Neuropathologica Communications.

[12]  K. Jellinger,et al.  Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. , 1998, Archives of neurology.

[13]  M S Buchsbaum,et al.  EEG delta, positron emission tomography, and memory deficit in Alzheimer's disease. , 1995, Neuropsychobiology.

[14]  C G Ballard,et al.  Fluctuations in attention , 2002, Neurology.

[15]  Charles D. Smith,et al.  Association between male gender and cortical Lewy body pathology in large autopsy series , 2010, Journal of Neurology.

[16]  E. David Williams,et al.  Nicotinic α4β2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations , 2008, NeuroImage.

[17]  S. Crowley.  Sleep behavior across the lifespan: How a model can expand our current understanding. , 2016, Sleep medicine reviews.

[18]  F. Mauguière,et al.  Thalamic deactivation at sleep onset precedes that of the cerebral cortex in humans , 2010, Proceedings of the National Academy of Sciences.

[19]  J. Trojanowski,et al.  Conversion between Mini‐Mental State Examination, Montreal Cognitive Assessment, and Dementia Rating Scale‐2 scores in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[20]  M. Onofrj,et al.  The Effects of a Cholinesterase Inhibitor Are Prominent in Patients With Fluctuating Cognition: A Part 3 Study of the Main Mechanism of Cholinesterase Inhibitors in Dementia , 2003, Clinical neuropharmacology.

[21]  D. Aarsland,et al.  ( I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study , 2013 .

[22]  John-Paul Taylor,et al.  Relevance of subcortical visual pathways disruption to visual symptoms in dementia with Lewy bodies , 2014, Cortex.

[23]  J. Booij,et al.  Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[24]  John-Paul Taylor,et al.  Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies , 2015, Neurobiology of Aging.

[25]  S. D. Penna,et al.  Cortical rhythms reactivity in AD, LBD and normal subjects: A quantitative MEG study , 2006, Neurobiology of Aging.

[26]  P. Scheltens,et al.  [123]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  G. McKhann.  Changing concepts of Alzheimer disease. , 2011, JAMA.

[28]  I. McKeith,et al.  Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[29]  H. Soininen,et al.  Diagnostic accuracy of alzheimer’s disease: A neuropathological study , 2009, Acta Neuropathologica.

[30]  B. Boot.  Comprehensive treatment of dementia with Lewy bodies , 2015, Alzheimer's Research & Therapy.

[31]  D. Jeste,et al.  Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies , 2003, Neurology.

[32]  J. O'Brien,et al.  Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias. , 2012, Brain : a journal of neurology.

[33]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[34]  G. Plazzi,et al.  From state dissociation to status dissociatus. , 2016, Sleep medicine reviews.

[35]  I G McKeith,et al.  Quantifying fluctuation in dementia with Lewy bodies, Alzheimer’s disease, and vascular dementia , 2000, Neurology.

[36]  E. Londos,et al.  Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study , 2014, BMJ Open.

[37]  E. Londos,et al.  Electroencephalogram Variability in Dementia with Lewy Bodies, Alzheimer’s Disease and Controls , 2008, Dementia and Geriatric Cognitive Disorders.

[38]  B. Boeve,et al.  Lewy body dementias , 2015, The Lancet.

[39]  J Taki,et al.  Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD , 2006, Neurology.

[40]  M. Steriade.  Grouping of brain rhythms in corticothalamic systems , 2006, Neuroscience.

[41]  Mark P. MacEachern,et al.  Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review , 2015, Movement disorders : official journal of the Movement Disorder Society.

[42]  J. Grace,et al.  Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease , 1998, The Lancet.